N-benzyl-N-(2-phenoxyethyl)amine | 55247-31-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N-benzyl-N-(2-phenoxyethyl)amine
• 英文别名: N-(2-Phenoxyethyl)benzylamine；N-(phenylmethyl)-2-phenoxyethanamine；Benzyl-(2-phenoxy-ethyl)-amine；N-benzyl-2-phenoxyethanamine
• CAS: 55247-31-9
• 化学式: C₁₅H₁₇NO
• mdl: MFCD03210906
• 分子量: 227.306
• InChiKey: XTNXLNGNJZRBRW-UHFFFAOYSA-N

物化性质

• 沸点：
  150-154 °C(Press: 0.3 Torr)
• 密度：
  1.052±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  17
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  21.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  N-benzyl-N-(2-phenoxyethyl)amine 在 盐酸 、 potassium carbonate 作用下， 以 乙醇 、 苯 为溶剂， 反应 80.25h， 生成 SKF 513 hydrochloride
  参考文献：
  名称：

  Structure–Activity relationships among novel phenoxybenzamine-Related β-Chloroethylamines

  摘要：

  A series of beta-chloroethylamines 5-18, structurally related to the irreversible alpha(1)-adrenoceptor antagonist phenoxy-benzamine [PB, N-benzyl-N-(2-chloroethyl)-N-(1-methyl-2-phenoxyethyl)amine hydrochloride, 1] and the competitive antagonist WB4101 [N-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)-N-[2-(2,6-dimethoxyphenoxy)ethyl]amine hydrochloride, 2], were synthesized and evaluated for their activity at alpha-adrenoceptors of the epididymal and the prostatic portion of young CD rat vas deferens. All compounds displayed irreversible antagonist activity. Most of them showed similar antagonism at both alpha(1)- and alpha(2)-adrenoceptors, whereas compounds 13 and 18, lacking substituents on both the phenoxy group and the oxyamino carbon chain, displayed a moderate alpha(1)-adrenoceptor selectivity (10-35 times), which was comparable to that of PB. Compounds 14 and 15, belonging to the benzyl series and bearing, respectively, a 2-ethoxyphenoxy and a 2-i-propoxyphenoxy moiety, were the most potent alpha(1)-adrenoceptor antagonists with an affinity value similar to that Of PB (pIC(50) values of 7.17 and 7.06 versus 7.27). Interestingly, several compounds were able to distinguish two alpha(1)-adrenoceptor subtypes in the epididymal tissue, as revealed by the discontinuity of their inhibition curves. A mean ratio of 24:76 for these alpha(1)-adrenoceptors was determined from compounds 8-10, 12, and 15-17. Furthermore, compounds 9, 10, 12, 16a, and 16b showed higher affinity towards the minor population of receptors, whereas compounds 8, 15, and 17 preferentially inhibited the major population of alpha(1)-adrenoceptors. In addition, selected pharmacological experiments demonstrated the complementary antagonism of the two series of compounds and their different, preferential affinity for one of the two alpha(1)-adrenoceptor subtypes. In conclusion, we found beta-chloroethylamines that demonstrate a multiplicity of alpha(1)-adrenoceptors in the epididymal portion of young CD rat vas deferens and, as a consequence, they are possible useful tools for alpha(1)-adrenoceptor characterization. (C) 2002 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0968-0896(01)00395-9
• 作为产物：
  描述：

  N-benzyl-2-phenoxyacetamide 在 dimethyl sulfide borane 作用下， 以 乙二醇二甲醚 为溶剂， 反应 16.0h， 以50%的产率得到N-benzyl-N-(2-phenoxyethyl)amine
  参考文献：
  名称：

  Structure–Activity relationships among novel phenoxybenzamine-Related β-Chloroethylamines

  摘要：

  A series of beta-chloroethylamines 5-18, structurally related to the irreversible alpha(1)-adrenoceptor antagonist phenoxy-benzamine [PB, N-benzyl-N-(2-chloroethyl)-N-(1-methyl-2-phenoxyethyl)amine hydrochloride, 1] and the competitive antagonist WB4101 [N-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)-N-[2-(2,6-dimethoxyphenoxy)ethyl]amine hydrochloride, 2], were synthesized and evaluated for their activity at alpha-adrenoceptors of the epididymal and the prostatic portion of young CD rat vas deferens. All compounds displayed irreversible antagonist activity. Most of them showed similar antagonism at both alpha(1)- and alpha(2)-adrenoceptors, whereas compounds 13 and 18, lacking substituents on both the phenoxy group and the oxyamino carbon chain, displayed a moderate alpha(1)-adrenoceptor selectivity (10-35 times), which was comparable to that of PB. Compounds 14 and 15, belonging to the benzyl series and bearing, respectively, a 2-ethoxyphenoxy and a 2-i-propoxyphenoxy moiety, were the most potent alpha(1)-adrenoceptor antagonists with an affinity value similar to that Of PB (pIC(50) values of 7.17 and 7.06 versus 7.27). Interestingly, several compounds were able to distinguish two alpha(1)-adrenoceptor subtypes in the epididymal tissue, as revealed by the discontinuity of their inhibition curves. A mean ratio of 24:76 for these alpha(1)-adrenoceptors was determined from compounds 8-10, 12, and 15-17. Furthermore, compounds 9, 10, 12, 16a, and 16b showed higher affinity towards the minor population of receptors, whereas compounds 8, 15, and 17 preferentially inhibited the major population of alpha(1)-adrenoceptors. In addition, selected pharmacological experiments demonstrated the complementary antagonism of the two series of compounds and their different, preferential affinity for one of the two alpha(1)-adrenoceptor subtypes. In conclusion, we found beta-chloroethylamines that demonstrate a multiplicity of alpha(1)-adrenoceptors in the epididymal portion of young CD rat vas deferens and, as a consequence, they are possible useful tools for alpha(1)-adrenoceptor characterization. (C) 2002 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0968-0896(01)00395-9

文献信息

• [EN] BENZENE, PYRIDINE, NAPHTALENE OR BENZOPHENONE DERIVATIVES AS INHIBITORS OF SQUALENE SYNTHETASE AND PROTEIN FARNESYLTRANSFERASE<br/>[FR] DERIVES DE BENZENE, PYRIDINE, NAPHTALENE OU BENZOPHENONE UTILISES COMME INHIBITEURS DE LA SQUALENE SYNTHETASE ET DE LA PROTEINE FARNESYLTRANSFERASE
  申请人：ABBOTT LABORATORIES

  公开号：WO1996034851A1

  公开（公告）日：1996-11-07

  (EN) The present invention provides a compound of formula (I), (II), (III) or (IV), processes for the preparation of the compounds of the invention, intermediates useful in these processes, a pharmaceutical composition, and methods of using the compounds of the invention.(FR) La présente invention se rapporte à des composés de la formule (I), (II), (III) ou (IV), aux procédés de préparation de ces composés, aux intermédiaires utilisés dans ces procédés, à une composition pharmaceutique et aux procédés d'utilisation de ces composés.

  该发明提供了公式（I），（II），（III）或（IV）的化合物，制备该发明化合物的方法，这些方法中有用的中间体，制药组合物以及使用该发明化合物的方法。
• [EN] NOVEL ANTITUMOUR COMPOUNDS WITH ANTIMITOTIC ACTIVITY<br/>[FR] NOUVEAUX COMPOSES ANTITUMORAUX A ACTIVITE ANTIMITOTIQUE
  申请人：PHARMACIA AB

  公开号：WO1995029155A1

  公开（公告）日：1995-11-02

  (EN) Novel N-acyl-aminoalkyl phenyl ether compounds having general formula (I), wherein A is an aromatic ring such as phenyl, thienyl, furyl, pyridyl; R1, R2 and R3 are selected from H, alkyl, halogen, electron acceptors and electron donors; m is 0, 1 or 2; R4 is H or lower alkyl; R5 is NR6R7, OR8 or lower alkyl or lower cycloalkyl; R6 and R7 are H or lower alkyl or lower cycloalkyl; R8 is lower alkyl or lower cycloalkyl; Y is O or S; n is 2 or 3; R9 is H or lower alkyl; X is O or CH2; R10, R11 and R12 are selected from H, 'alkyl', halogen, electron acceptors and electron donors or one of them may be (a), wherein Z is a bond, O, CO or CH2; and wherein B is an aromatic ring such as phenyl or pyridyl and R13, R14 and R15 are selected from H, 'alkyl', halogen, electron acceptors and electron donors, and pharmaceutically acceptable salts thereof. The invention also comprises pharmaceuticals, especially anticancer and/or antimitotic drugs, comprising one or more of the above-mentioned compounds.(FR) Nouveaux composés d'éther phénylique de N-acyl-aminoalkyle de la formule générale (I) dans laquelle A représente un cycle aromatique tel que phényle, thiényle, furyle, pyridyle; R1, R2 et R3 sont choisis entre H, alkyle, halogène, des accepteurs d'électrons et des donneurs d'électrons; m vaut 0, 1 ou 2; R4 représente H ou alkyle inférieur; R5 représente NR6R7, OR8 ou alkyle inférieur ou cycloalkyle inférieur; R6 et R7 représentent H ou alkyle inférieur ou cycloalkyle inférieur; R8 représente alkyle inférieur ou cycloalkyle inférieur; Y représente O ou S; n vaut 2 ou 3; R9 représente H ou alkyle inférieur; X représente O ou CH2; R10, R11 et R12 sont choisis entre H, 'alkyle', halogène, des accepteurs d'électrons et des donneurs d'électrons, ou l'un d'entre eux peut représenter (a), Z représentant une liaison, O, CO ou CH2; et B représente un cycle aromatique tel que phényle ou pyridyle, et R13, R14 et R15 sont choisis entre H, 'alkyle', halogène, des accepteurs d'électrons et des donneurs d'électrons; et leurs sels pharmaceutiquement acceptables. L'invention se rapporte également à des produits pharmaceutiques, en particulier des médicaments anticancéreux et/ou antimitotiques, comprenant au moins un des composés précités.

  （中文翻译）具有通式（I）的新型N-酰基-氨基烷基苯醚化合物，其中A是芳香环，如苯基，噻吩基，呋喃基，吡啶基；R1、R2和R3选自H，烷基，卤素，电子受体和电子给体；m为0、1或2；R4为H或较低的烷基；R5为NR6R7、OR8或较低的烷基或较低的环烷基；R6和R7为H或较低的烷基或较低的环烷基；R8为较低的烷基或较低的环烷基；Y为O或S；n为2或3；R9为H或较低的烷基；X为O或CH2；R10、R11和R12选自H、'烷基'、卤素、电子受体和电子给体，或其中一个可能是（a），其中Z为键，O，CO或CH2；B为芳香环，如苯基或吡啶基，R13、R14和R15选自H、'烷基'、卤素、电子受体和电子给体，以及其药学上可接受的盐。本发明还包括药物，特别是包含上述化合物之一或多个的抗癌和/或抗有丝分裂药物。
• Discovery of an Imine Reductase for Reductive Amination of Carbonyl Compounds with Sterically Challenging Amines
  作者：Fei-Fei Chen、Xue-Feng He、Xin-Xin Zhu、Zhi Zhang、Xin-Yuan Shen、Qi Chen、Jian-He Xu、Nicholas J. Turner、Gao-Wei Zheng

  DOI：10.1021/jacs.2c11354

  日期：——

  structurally diverse amines is of fundamental significance in the pharmaceutical industry due to the ubiquitous presence of amine motifs in biologically active molecules. Biocatalytic reductive amination for amine production has attracted great interest owing to its synthetic advantages. Herein, we report the direct synthesis of a wide range of sterically demanding secondary amines, including several

  由于生物活性分子中普遍存在胺基序，结构多样的胺的合成在制药工业中具有根本意义。用于胺生产的生物催化还原胺化由于其合成优势而引起了人们的极大兴趣。在此，我们报道了通过使用亚胺还原酶对羰基底物和大胺亲核试剂进行还原胺化，直接合成了各种空间要求较高的仲胺，包括几种重要的活性药物成分和药物中间体。该路线成功的关键是从卡门贝尔青霉中鉴定出具有不寻常底物特异性的亚胺还原酶及其进一步的工程设计，从而能够适应各种空间要求高的胺亲核试剂，包括直链烷基和（杂）芳族（氧基）烷基取代基和最终胺产物的形成，转化率高达 >99%。该生物催化路线的实用性已通过其在抗甲状旁腺功能亢进药物西那卡塞的制备合成中的应用得到证明。
• Asymmetric Substitution by Alkynyl Copper Driven Dearomatization and Rearomatization
  作者：Yu‐Ze Sun、Zi‐Yang Ren、Yuan‐Xiang Yang、Yang Liu、Guo‐Qiang Lin、Zhi‐Tao He

  DOI：10.1002/anie.202314517

  日期：2023.11.20

  Catalytic asymmetric transformations by dearomatization have developed into a widely applicable synthetic strategy, but heavily relied on the use of arenes bearing a heteroatom. In this case, the dearomatization is facilitated by the involvement of a p‐orbital electron of the heteroatom. Different from the conventional substrate‐dependent model, here we demonstrate that the activation by a d‐orbital electron of the transition‐metal center can serve as a driving force for dearomatization, and is applied to the development of a novel asymmetric alkynyl copper facilitated remote substitution reaction. A newly modified PyBox chiral ligand enables the construction of valuable diarylmethyl and triarylmethyl skeletons in high enantioselectivities. An unexpected tandem process involving sequential remote substitution/cyclization/1,5‐H shift leads to the formation of the enantioenriched C−N axis. A gram‐scale reaction and various downstream transformations highlight the robustness of this method and the potential transformations of the products. Preliminary mechanistic studies reveal a mononuclear Cu‐catalyzed remote substitution process.

  摘要脱芳烃催化不对称转化已发展成为一种广泛适用的合成策略，但主要依赖于使用带有一个杂原子的烷烃。在这种情况下，杂原子的 p 轨道电子的参与促进了脱芳香化。与传统的底物依赖模型不同，我们在此证明了过渡金属中心 d 轨道电子的激活可以作为脱芳香化的驱动力，并将其应用于新型不对称炔铜促进远程取代反应的开发。一种新修饰的 PyBox 手性配体能够以高对映选择性构建有价值的二芳基甲基和三芳基甲基骨架。一个意想不到的串联过程（包括连续的远程取代/环化/1,5-H 转变）导致了对映体富集的 C-N 轴的形成。克级反应和各种下游转化过程凸显了该方法的稳健性和产物的潜在转化能力。初步的机理研究揭示了一种单核铜催化的远程取代过程。
• N-benzyl-N-phenoxyethylamines and agricultural and horticultural bactericides
  申请人：MITSUBISHI GAS CHEMICAL COMPANY, INC.

  公开号：EP0454492A1

  公开（公告）日：1991-10-30

  Compounds of formula (I) wherein m is 1 or 2 or an agriculturally acceptable acid addition salt thereof are useful as agricultural and horticultural bactericides.

  式 (I) 的化合物 式中 m 为 1 或 2 的化合物或其农业上可接受的酸加成盐可用作农业和园艺杀菌剂。